Imaging Technologies and Diagnostic tests of Biomarkers


In clinical trials using imaging, biomarkers and response criteria are used to assess the tumor evolution with therapy. Imaging biomarkers are often root contributors to a clinical trial’s endpoints, but they are not the same. Diagnostic tests and the biological biomarker (biomarkers) they measure are often classified based on the circumstances under which they are used. Biomarkers provide information about a patient at virtually every stage of care. They can help doctors evaluate the likelihood that a patient will develop a disease, diagnose a disorder, evaluate the severity of a disorder and/or its likely progression, determine optimal treatment strategies and monitor response to treatment.


    Related Conference of Imaging Technologies and Diagnostic tests of Biomarkers

    September 15-16, 2025

    29th Global Congress on Biotechnology

    Paris, France
    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France
    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, Aland Islands
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE

    Imaging Technologies and Diagnostic tests of Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in